Using 3D protein structures to derive 3D-QSARs

Hopfinger, 1997, Construction of 3DQSAR models using 4D-QSAR analysis formalism, J. Am. Chem. Soc., 119, 10509, 10.1021/ja9718937 Vedani, 2002, 5D-QSAR: the key for simulating induced fit?, J. Med. Chem., 45, 2139, 10.1021/jm011005p Hansch, 1964, ρ–σ–π Analysis. A method for the correlation of biological activity and chemical structure, J. Am. Chem. Soc., 86, 1616, 10.1021/ja01062a035 Hansch, 1972, Linear relationships between lipophilic character and biological activity of drugs, J. Pharm. Sci., 61, 1, 10.1002/jps.2600610102 Fujita, 1997, Recent success stories leading to commercializable bioactive compounds with the aid of traditional QSAR procedures, Quant. Struct. Act. Relat., 16, 107, 10.1002/qsar.19970160202 Cramer, 1988, Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins, J. Am. Chem. Soc., 110, 5959, 10.1021/ja00226a005 Goodford, 1985, A computational procedure for determining energetically favorable binding sites on biologically important macromolecules, J. Med. Chem., 28, 849, 10.1021/jm00145a002 Baroni, 1993, Generating optimal linear PLS estimations (GOLPE): an advanced chemometric tool for handling 3D-QSAR problems, Quant. Struct. Act. Relat., 12, 9, 10.1002/qsar.19930120103 Klebe, 1994, Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity, J. Med. Chem., 37, 4130, 10.1021/jm00050a010 Cruciani, 2000, VolSurf: a new tool for the pharmacokinetic optimization of lead compounds, Eur. J. Pharm. Sci., 11, S29, 10.1016/S0928-0987(00)00162-7 Crivori, 2000, Predicting blood–brain barrier permeation from three-dimensional molecular structure, J. Med. Chem., 43, 2204, 10.1021/jm990968+ Ferguson, 1997, EVA: a new theoretically based molecular descriptor for use in QSAR/QSPR analysis, J. Comput. Aided Mol. Des., 11, 143, 10.1023/A:1008026308790 Grootenhuis, 1995, Correlation of binding affinities with non-bonded interaction energies of thrombin–inhibitor complexes, Acta Cryst., D51, 560 Holloway, 1995, A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site, J. Med. Chem., 38, 305, 10.1021/jm00002a012 Aqvist, 1994, A new method for predicting binding affinity in computer-aided drug design, Protein Eng., 7, 385, 10.1093/protein/7.3.385 Tominaga, 2004, General model for estimation of the inhibition of protein kinases using Monte Carlo simulations, J. Med. Chem., 47, 2534, 10.1021/jm0304358 Venkatarangan, 1999, Prediction of ligand–receptor binding thermodynamics by free energy force field three-dimensional quantitative structure–activity relationship analysis: applications to a set of glucose analogue inhibitors of glycogen phosphorylase, J. Med. Chem., 42, 2169, 10.1021/jm980515p Gohlke, 2002, DrugScore meets CoMFA: adaptation of fields for molecular comparison (AFMoC) or how to tailor knowledge-based pair-potentials to a particular protein, J. Med. Chem., 45, 4153, 10.1021/jm020808p Ortiz, 1995, Prediction of drug binding affinities by comparative binding energy analysis, J. Med. Chem., 38, 2681, 10.1021/jm00014a020 Wade, 1998, Comparative binding energy analysis, Perspect. Drug Discov. Des., 9, 19, 10.1023/A:1027247618908 Vinkers, 2003, Inhibition and substrate recognition – a computational approach applied to HIV protease, J. Comput. Aided Mol. Des., 17, 567, 10.1023/B:JCAM.0000005748.19093.e8 Murcia, 2004, Virtual screening with flexible docking and COMBINE-based models. Application to a series of factor Xa inhibitors, J. Med. Chem., 47, 805, 10.1021/jm030137a Wang, 2001, Comparative binding energy (COMBINE) analysis of influenza neuraminidase–inhibitor complexes, J. Med. Chem., 44, 671, 10.1021/jm001070j Kmunicek, 2001, Comparative binding energy (COMBINE) analysis of the substrate specificity of haloalkane dehalogenase from xanthobacter autotrophicus GJ10, Biochemistry, 40, 8905, 10.1021/bi010464p Wang, 2002, Comparative binding energy (COMBINE) analysis of OppA–peptide complexes to relate structure to binding thermodynamics, J. Med. Chem., 45, 4828, 10.1021/jm020900l Schleinkofer, 2004, Comparative structural and energetic analysis of WW domain-peptide interactions, J. Mol. Biol., 344, 865, 10.1016/j.jmb.2004.09.063 Wang, 2004, How optimal are the binding energetics of barnase and barstar?, Biophys. J., 12, 1563 Tomic, 2000, Nuclear receptor-DNA binding specificity: a COMBINE and Free-Wilson QSAR analysis, J. Med. Chem., 43, 1780, 10.1021/jm9911175 Jansen, 2004, Target-biased scoring approaches and expert systems in structure-based virtual screening, Curr. Opin. Chem. Biol., 8, 359, 10.1016/j.cbpa.2004.06.002 Gohlke, 2001, Statistical potentials and scoring functions applied to protein–ligand binding, Curr. Opin. Struct. Biol., 11, 231, 10.1016/S0959-440X(00)00195-0 Pearlman, 1995, AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules, Comp. Phys. Commun., 91, 1, 10.1016/0010-4655(95)00041-D Madura, 1995, Electrostatics and diffusion of molecules in solution: simulations with the university of Houston brownian dynamics program, Comput. Phys. Commun., 91, 57, 10.1016/0010-4655(95)00043-F Pastor, 1997, Simulation of alternative binding modes in a structure-based QSAR study of HIV-1 protease inhibitors, J. Mol. Graph. Model., 15, 364, 10.1016/S1093-3263(98)00007-2